Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM

Albert H. Hauber; Juan Marcos Gonzalez; Joshua Dylan Posner; Ateesha F. Mohamed; Y Qian; Brett Hauber; Juan Marcos Gonzalez; Joshua Dylan Posner; Ateesha F. Mohamed; B Tombal; JJ Body; F Gatta; J Arellano

Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM

Qian, Y., Hauber, A., Gonzalez, J., Posner, J., Mohamed, A., Tombal, B., Body, JJ., Gatta, F., & Arellano, J. (2014). Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM. Journal of Clinical Oncology, 32(4, Suppl.), Abstract 117.

Copy citation